Biomaterial-mediated fibrotic responses
生物材料介导的纤维化反应
基本信息
- 批准号:8135530
- 负责人:
- 金额:$ 31.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-22 至 2013-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdherenceAdhesionsAdverse reactionsAnimal ModelAntibodiesAreaBindingBiocompatible MaterialsCell ProliferationCell physiologyCellsChemotaxisCicatrixCoagulation ProcessCollagenCollectionComplexDepositionDevelopmentEngineeringEnvironmentEpitopesEventFailureFibrinFibrinogenFibroblastsForeign-Body ReactionFoundationsFutureGoalsGrantGrowth FactorHistocompatibilityHistologyImmuneImplantIndividualInfiltrationInflammatoryInflammatory ResponseIntegrinsInternal Breast ProsthesisInvestigationKnockout MiceKnowledgeLeadLigamentsMacrophage-1 AntigenMediatingMedical DeviceModelingMolecularMolecular BiologyNew AgentsPathogenesisPeptidesPhagocytesPharmaceutical PreparationsProcessProductionPropertyProteinsReactionRecruitment ActivityReportingResearchRoleSafetySeriesSeveritiesSimulateSiteSurfaceSystems BiologyTechniquesTestingThromboplastinTimeTissuesTransgenic AnimalsUp-RegulationWorkWound Healingattenuationbasecapsulechemokinecytokinedesignimplant materialimplantable deviceimplantationimprovedinhibitor/antagonistmathematical modelmedical implantnovelnovel strategiesresponsesensorsuccesstool
项目摘要
DESCRIPTION (provided by applicant): Biomaterial-mediated inflammatory and fibrotic responses are responsible for the failure of many medical implants. To engineer biomaterials to evoke desired tissue responses, it is important to improve our current understanding of the pathogenesis of biomaterial-mediated fibrotic reactions. Since phagocyte products have been shown to have a strong influence fibrotic processes (i.e. fibroblast proliferation and collagen production), we have hypothesized that, by reducing the extent of inflammatory responses, the degree of fibrotic reactions to medical implants could lessen. Based on the information gained from our previous investigation, we have assumed that biomaterial-mediated fibrotic reactions are comprised of following continuous processes. First, shortly after implantation, inflammatory cells (mostly phagocytes) are recruited to the implantation site by transmigration. Second, the release of chemokines by implant-associated cells attract many phagocytes which migrate toward the implant. Third, phagocyte adhesion on implants is promoted by phagocyte Mac-1 integrin and newly exposed P1/P2 epitopes on adsorbed fibrinogen. Fourth, Mac-1 integrin: P1/P2 epitope engagement triggers phagocyte activation and later release of pro-fibrotic products, including cytokines and tissue factor. Fifth, the localized collection of tissue factor by adherent phagocytes leads to full formation of a fibrin clot on implant surfaces. Finally, this implant-bound fibrin clot provides a superior environment for fibroblast integration, proliferation, collagen production, and fibrotic tissue formation. The goal of this investigation is to first identify the critical steps in leading to biomaterial-mediated fibrotic reactions using specific antibodies and knock-out mice. Subsequent studies will be carried out to assess the potential influence of various antagonists and inhibitors on modifying those critical cellular responses and final fibrtotic tissue formation. Using system biology tools, we hope to break new ground in studying individual critical cellular responses and then whole foreign body reactions. Special emphasis will be paid to the potential roles and interactions between different parameters (biomaterials, proteins, and cells) and those vital cellular responses in promoting foreign body reactions. The comprehensive and systematic information gained from this work would help to develop novel pharmacological and engineering strategies for rational design of biomaterials with desired tissue compatibility and safety. Biomaterial-mediated fibrotic responses are one of the leading causes of implant failure. The goal of this research is to identify and study the critical responses of these unwanted immune reactions using both cell/molecular biology/histology techniques and mathematical modeling. This information is of utmost importance for the design and development of better and safer medical devices.
描述(由申请人提供):生物材料介导的炎症和纤维化反应是许多医疗植入物失败的原因。为了设计生物材料来引起所需的组织反应,提高我们目前对生物材料介导的纤维化反应发病机制的理解是很重要的。由于吞噬细胞产物已被证明对纤维化过程(即成纤维细胞增殖和胶原蛋白产生)有很强的影响,我们假设,通过减少炎症反应的程度,可以减轻对医疗植入物的纤维化反应的程度。根据我们之前的研究,我们假设生物材料介导的纤维化反应是由以下连续过程组成的。首先,在植入后不久,炎症细胞(主要是吞噬细胞)通过转运被招募到植入部位。其次,移植物相关细胞释放的趋化因子吸引了许多向移植物迁移的吞噬细胞。第三,吞噬细胞Mac-1整合素和新暴露的P1/P2表位吸附在纤维蛋白原上,促进了植入物上的吞噬细胞粘附。第四,Mac-1整合素:P1/P2表位结合触发吞噬细胞活化,随后释放促纤维化产物,包括细胞因子和组织因子。第五,附着的吞噬细胞对组织因子的局部收集导致植入物表面充分形成纤维蛋白凝块。最后,这种植体结合的纤维蛋白凝块为成纤维细胞的整合、增殖、胶原蛋白的产生和纤维化组织的形成提供了优越的环境。本研究的目的是首先利用特异性抗体和敲除小鼠确定导致生物材料介导的纤维化反应的关键步骤。随后的研究将评估各种拮抗剂和抑制剂对改变这些关键细胞反应和最终纤维化组织形成的潜在影响。利用系统生物学工具,我们希望在研究个体关键细胞反应和整个异物反应方面取得新的突破。将特别强调不同参数(生物材料、蛋白质和细胞)之间的潜在作用和相互作用,以及促进异体反应的重要细胞反应。从这项工作中获得的全面和系统的信息将有助于开发新的药理学和工程策略,以合理设计具有理想组织相容性和安全性的生物材料。生物材料介导的纤维化反应是导致植入失败的主要原因之一。本研究的目的是利用细胞/分子生物学/组织学技术和数学建模来识别和研究这些不需要的免疫反应的关键反应。这些信息对于设计和开发更好、更安全的医疗设备至关重要。
项目成果
期刊论文数量(29)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The effect of erythropoietin on autologous stem cell-mediated bone regeneration.
- DOI:10.1016/j.biomaterials.2013.06.031
- 发表时间:2013-10
- 期刊:
- 影响因子:14
- 作者:Nair, Ashwin M.;Tsai, Yi-Ting;Shah, Krishna M.;Shen, Jinhui;Weng, Hong;Zhou, Jun;Sun, Xiankai;Saxena, Ramesh;Borrelli, Joseph, Jr.;Tang, Liping
- 通讯作者:Tang, Liping
The effect of incorporation of SDF-1alpha into PLGA scaffolds on stem cell recruitment and the inflammatory response.
- DOI:10.1016/j.biomaterials.2010.01.144
- 发表时间:2010-05
- 期刊:
- 影响因子:14
- 作者:Thevenot, Paul T.;Nair, Ashwin M.;Shen, Jinhui;Lotfi, Parisa;Ko, Cheng-Yu;Tang, Liping
- 通讯作者:Tang, Liping
Injectable citrate-based mussel-inspired tissue bioadhesives with high wet strength for sutureless wound closure.
- DOI:10.1016/j.biomaterials.2012.07.055
- 发表时间:2012-11
- 期刊:
- 影响因子:14
- 作者:Mehdizadeh, Mohammadreza;Weng, Hong;Gyawali, Dipendra;Tang, Liping;Yang, Jian
- 通讯作者:Yang, Jian
Intraocular pressure changes: an important determinant of the biocompatibility of intravitreous implants.
- DOI:10.1371/journal.pone.0028720
- 发表时间:2011
- 期刊:
- 影响因子:3.7
- 作者:Zou L;Nair A;Weng H;Tsai YT;Hu Z;Tang L
- 通讯作者:Tang L
A Predictive Tool for Foreign Body Fibrotic Reactions Using 2-Dimensional Computational Model.
使用二维计算模型预测异物纤维化反应的工具。
- DOI:10.2147/oab.s14254
- 发表时间:2011
- 期刊:
- 影响因子:0
- 作者:Su,Jianzhong;Todorov,Michail;Gonzales,HumbertoPerez;Perkins,Larrissa;Kojouharov,Hristo;Weng,Hong;Tang,Liping
- 通讯作者:Tang,Liping
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Liping Tang其他文献
Liping Tang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Liping Tang', 18)}}的其他基金
Biomolecule releasing adhesive for cell-mediated labral repair
用于细胞介导的盂唇修复的生物分子释放粘合剂
- 批准号:
10736334 - 财政年份:2023
- 资助金额:
$ 31.59万 - 项目类别:
STRUCTURE OF THE HYDROGENASE FROM THIOCAPSA ROSEOPERSICINA
桃红硫解酶的氢化酶的结构
- 批准号:
7602770 - 财政年份:2007
- 资助金额:
$ 31.59万 - 项目类别:
BIOCOMPATIBILITY: SURFACE INITIATED BIOCHEMISTRY
生物相容性:表面引发的生物化学
- 批准号:
7028945 - 财政年份:2005
- 资助金额:
$ 31.59万 - 项目类别:
BIOCOMPATIBILITY: SURFACE INITIATED BIOCHEMISTRY
生物相容性:表面引发的生物化学
- 批准号:
6909313 - 财政年份:2005
- 资助金额:
$ 31.59万 - 项目类别:
BIOCOMPATIBILITY: SURFACE INITIATED BIOCHEMISTRY
生物相容性:表面引发的生物化学
- 批准号:
7216703 - 财政年份:2005
- 资助金额:
$ 31.59万 - 项目类别:
FOREIGN BODY REACTION AND DEVICE CENTERED INFECTION
异物反应和设备中心感染
- 批准号:
6415177 - 财政年份:2000
- 资助金额:
$ 31.59万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 31.59万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 31.59万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 31.59万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 31.59万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 31.59万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 31.59万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 31.59万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 31.59万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 31.59万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 31.59万 - 项目类别: